The immunohistochemistry assay revealed that NCX1 expression was higher in prostate cancer tissues than in benign prostatic hyperplasia tissues (Figure 1A), and NCX1 expression increased as prostate cancer grade increased. Here, SLC8A1 is linked to prostate cancer.